The company aims to start a pivotal trial this year, file for 510(k) clearance in 2027 and launch the device in 2028.

An autonomous platform uses machine learning and patterned light to detect and terminate cardiac arrhythmias in real time without electrical shocks.

Artificial intelligence may be reshaping modern medicine, but when it comes to their own health, patients still want to know a real person is watching the screen. Researchers at the University of ...

Thanks to the alternating single-double nature of the bonds, electrons in these orbitals end up delocalized; the differences between the bonds become a bit irrelevant, and the molecule is best viewed ...

IISc and Pratiksha Trust launch a groundbreaking project to develop AI-powered brain co-processors for stroke rehabilitation.

The Indian Institute of Science has launched a groundbreaking project to develop brain co-processors, merging neuromorphic ...

Ad fraud is the most prolific form of cybercrime. So why haven't you heard of it? TOKYO, JP / ACCESS Newswire / March ...

In the era of A.I. agents, many Silicon Valley programmers are now barely programming. Instead, what they’re doing is deeply, ...

The title says it all, and then promptly laughs at you for believing it would be that simple. Directed by Gore Verbinski, the film imagines a near-future where technology is not overtly evil, just ...

Insulet Stock: why GLP-1 fears are overblown, with growth driven by Europe/MENA expansion. Read here for a detailed analysis on PODD stock.

Pomdoctor Limited ('Pomdoctor' or the 'Company') (NASDAQ: POM), a leading online medical services platform for chronic diseases in China, today announced a strategic upgrade centered on the core track ...